DiaMedica Therapeutics Inc.
DMACNasdaqCIK 1401040HealthcareFiscal year ends Dec 31
Reports and events: 125 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-08-1016:37 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001437749-26-026792 |
| 2026-08-1016:35 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-026790 |
| 2026-05-2116:30 ET | 8-K | 5.07 Shareholder vote results | 0001437749-26-018106 |
| 2026-05-0616:38 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001437749-26-015220 |
| 2026-05-0616:36 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-015218 |
| 2026-04-0116:06 ET | DEF 14A | Proxy statementPeriod 2026-05-20 | 0001437749-26-010879 |
| 2026-03-3118:40 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-010409 |
| 2026-03-3017:34 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001437749-26-010342 |
| 2026-01-0509:15 ET | 8-K | 8.01 Other events | 0001437749-26-000175 |
| 2025-12-1808:45 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-038211 |
| 2025-11-1216:33 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001437749-25-034469 |
| 2025-11-1216:31 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-25-034467 |
| 2025-08-1217:27 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001437749-25-026286 |
| 2025-08-1216:17 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001437749-25-026207 |
| 2025-08-1216:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-25-026205 |
| 2025-08-0608:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-024956 |
| 2025-07-2108:01 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-023048 |
| 2025-07-1708:05 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-25-022877 |
| 2025-05-1516:46 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001437749-25-017239 |
| 2025-05-1316:31 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001437749-25-016488 |
| 2025-05-1316:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-25-016487 |
| 2025-03-2807:14 ET | DEF 14A | Proxy statementPeriod 2025-05-15 | 0001437749-25-009696 |
| 2025-03-1716:32 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001437749-25-008018 |
| 2025-03-1716:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-25-008014 |
| 2025-03-0608:30 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001437749-25-006379 |
| 2025-02-2416:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-25-004891 |
| 2024-11-1316:22 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001437749-24-034925 |
| 2024-11-1316:21 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-24-034922 |
| 2024-08-0716:32 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-24-025200 |
| 2024-08-0716:31 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001437749-24-025198 |
| 2024-06-2608:16 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-24-021220 |
| 2024-06-2608:01 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-24-021219 |
| 2024-05-2316:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001437749-24-018140 |
| 2024-05-0816:34 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001437749-24-015381 |
| 2024-05-0816:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-24-015378 |
| 2024-04-1016:36 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001437749-24-011645 |
| 2024-04-0406:05 ET | DEF 14A | Proxy statementPeriod 2024-05-22 | 0001437749-24-010985 |
| 2024-03-1916:17 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001437749-24-008522 |
| 2024-03-1916:16 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-24-008521 |
| 2023-11-1316:55 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001437749-23-031671 |
| 2023-11-1316:52 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-23-031669 |
| 2023-09-0516:15 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001437749-23-025203 |
| 2023-08-1416:29 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001437749-23-023708 |
| 2023-08-1416:25 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-23-023698 |
| 2023-06-2108:42 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-23-017922 |
| 2023-06-2108:25 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-23-017917 |
| 2023-06-2108:16 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-23-017914 |
| 2023-05-3008:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-23-016029 |
| 2023-05-2217:01 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-23-015488 |
| 2023-05-1816:30 ET | 8-K | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001437749-23-015120 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:09 ET. Listed shows no prices and gives no investment advice.